Mitochondrial encephalomyopathies arise from mutations in the mitochondrial or nuclear genome and result in defective energy metabolism. Investigation of cellular pathophysiology in these disorders has been limited to nonneuronal explant cultures such as fibroblasts and myoblasts. While investigating mitochondrial structure and function in fibroblasts obtained from control and cytochrome oxidasedeficient (COX) patients, we observed possible abnormalities by vital dye confocal microscopy. Most notable were swelling, reticulation (e.g., intricate fusion of mitochondria), and proliferation of mitochondria. However, a detailed quantitative comparison of mitochondrial morphology in age-, sex-, and passage-matched cultures revealed no significant differences between control and cytochrome oxidase-deficient fibroblasts, nor any differences with passage. In addition, COX fibroblasts exhibited no obvious impairment of intracellular calcium handling, measured by fura-2. These results indicate that cytochrome oxidase deficiency, at the level in these cultures, does not produce structural or ionic concentration alterations in fibroblasts. Future investigation of the pathophysiology of this respiratory chain disorder may require excitable tissue. r 1997 Academic Press
INTRODUCTION
Mitochondrial encephalomyopathies are a broad category of human neurological and systemic disorders resulting from defective energy metabolism (for reviews see DiMauro & Moraes, 1993; DeVivo, 1993; Harding, 1991; Luft, 1994; Scholte, 1988; Wallace, 1992 Wallace, , 1994 . The genetic basis underlying these disorders is as varied as the enzymes and proteins involved in the cellular production of ATP. Substrate delivery and the maintenance of the mitochondrial electron transport system (ETS) are the most likely components of energy metabolism in which a genomic mutation would have severe clinical consequences. Mitochondria contain a small genome (mtDNA) which is separate from the nuclear genome (nDNA) and encodes 13 proteins of the ETS, as well as 22 tRNAs and 2 rRNAs required for mtDNA transcription and translation (Alberts et al., 1989; Wallace, 1989) . The remaining enzymes of the ETS, Kreb's cycle enzymes, DNA replication enzymes, aminoacyl-tRNA synthetases, RNA polymerases, protein import chaperones, and structural proteins are encoded by the nuclear genome (Alberts et al., 1989; Martinus et al., 1995; Pfanner et al., 1992; Schatz, 1991) . Mutations in mtDNA may involve point mutations in tRNA or ETS genes or replication errors resulting in large deletions or duplications (DiMauro & Moraes, 1993; Poulton & Holt, 1994) . Clinical diagnosis of nuclear-encoded defects of ETS are often based on biochemical and histochemical assays of fibroblast cultures or muscle biopsies (DiMauro & Moraes, 1993) . Cytochrome oxidase (COX) deficiency is one of the more frequently encountered clinical syndromes arising from a nDNA mutation (DiMauro et al., 1988; DiMauro & Moraes, 1993; Scholte, 1988) .
